Amphastar Pharmaceuticals logo
Amphastar Pharmaceuticals AMPH
$ 45.51 2.14%

Quarterly report 2024-Q3
added 11-07-2024

report update icon

Amphastar Pharmaceuticals Cost of Revenue 2011-2024 | AMPH

Annual Cost of Revenue Amphastar Pharmaceuticals

2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011
293 M 250 M 238 M 207 M 190 M 188 M 150 M 151 M 174 M 159 M 143 M 114 M -

All numbers in USD currency

Indicator range from annual reports

Maximum Minimum Average
293 M 114 M 188 M

Quarterly Cost of Revenue Amphastar Pharmaceuticals

2024-Q3 2024-Q2 2023-Q4 2023-Q3 2023-Q2 2023-Q1 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1
89.3 M 87.2 M - 72.2 M 73 M 66.2 M - 61.6 M 60.1 M 64.5 M - 61 M 54.3 M 58.1 M - 46.9 M 52.6 M 47.9 M - 44.9 M 46.7 M 48.9 M - 46.3 M 45 M 41.4 M - 37.4 M 38.4 M 33.8 M - 36.6 M 36.3 M 34.5 M - 46.3 M 40.5 M 43.6 M - 47.9 M 34 M 33.4 M - 39 M 35 M - - - - - - - - -

All numbers in USD currency

Indicator range from quarterly reporting

Maximum Minimum Average
89.3 M 33.4 M 50.1 M